Improved antiproliferative activity of 1,3,4-thiadiazole-containing histone deacetylase (HDAC) inhibitors by introduction of the heteroaromatic surface recognition motif
- PMID: 25311567
- DOI: 10.1016/j.bmc.2014.09.039
Improved antiproliferative activity of 1,3,4-thiadiazole-containing histone deacetylase (HDAC) inhibitors by introduction of the heteroaromatic surface recognition motif
Abstract
A series of 1,3,4-thiadiazole-containing hydroxamic acids, in accord with the common pharmacophore of histone deacetylase (HDAC) inhibitors (a Zn(2+) binding moiety-a linker-a surface recognition motif), was identified as submicromolar HDAC inhibitors by our group. In this study, we continued our efforts to develop 1,3,4-thiadiazole bearing hydroxamate analogues by modifying the surface recognition motif. We found that 1,3,4-thiadiazoles having a heteroaromatic substituent showed better HDAC inhibitory activity in enzymatic assay and higher antiproliferative potency in cellular assay compared to SAHA.
Keywords: 1,3,4-Thiadiazole; Antiproliferation; Histone deacetylase inhibitor; Hydroxamic acid; Surface recognition motif.
Copyright © 2014 Elsevier Ltd. All rights reserved.
Similar articles
-
Design, synthesis and preliminary bioactivity studies of 1,3,4-thiadiazole hydroxamic acid derivatives as novel histone deacetylase inhibitors.Bioorg Med Chem. 2012 Jun 15;20(12):3865-72. doi: 10.1016/j.bmc.2012.04.032. Epub 2012 Apr 21. Bioorg Med Chem. 2012. PMID: 22579621
-
2,5-Disubstituted-1,3,4-oxadiazoles/thiadiazole as surface recognition moiety: design and synthesis of novel hydroxamic acid based histone deacetylase inhibitors.Bioorg Med Chem Lett. 2011 Oct 1;21(19):5735-8. doi: 10.1016/j.bmcl.2011.08.022. Epub 2011 Aug 8. Bioorg Med Chem Lett. 2011. PMID: 21875796
-
Alkyl piperidine and piperazine hydroxamic acids as HDAC inhibitors.Bioorg Med Chem Lett. 2011 Apr 15;21(8):2305-8. doi: 10.1016/j.bmcl.2011.02.085. Epub 2011 Feb 26. Bioorg Med Chem Lett. 2011. PMID: 21420859
-
Structure-activity relationships of hydroxamate-based histone deacetylase-8 inhibitors: reality behind anticancer drug discovery.Future Med Chem. 2017 Dec;9(18):2211-2237. doi: 10.4155/fmc-2017-0130. Epub 2017 Nov 28. Future Med Chem. 2017. PMID: 29182018 Review.
-
Inhibitors of histone deacetylase as antitumor agents: A critical review.Bioorg Chem. 2016 Aug;67:18-42. doi: 10.1016/j.bioorg.2016.05.005. Epub 2016 May 17. Bioorg Chem. 2016. PMID: 27239721 Review.
Cited by
-
A comparison between observed and DFT calculations on structure of 5-(4-chlorophenyl)-2-amino-1,3,4-thiadiazole.Sci Rep. 2019 Dec 17;9(1):19280. doi: 10.1038/s41598-019-55793-5. Sci Rep. 2019. PMID: 31848439 Free PMC article.
-
Thiadiazole derivatives as anticancer agents.Pharmacol Rep. 2020 Oct;72(5):1079-1100. doi: 10.1007/s43440-020-00154-7. Epub 2020 Sep 3. Pharmacol Rep. 2020. PMID: 32880874 Free PMC article. Review.
-
Significance of Five-Membered Heterocycles in Human Histone Deacetylase Inhibitors.Molecules. 2023 Jul 27;28(15):5686. doi: 10.3390/molecules28155686. Molecules. 2023. PMID: 37570656 Free PMC article. Review.
-
Suberoylanilide Hydroxamic Acid Analogs with Heteroaryl Amide Group and Different Chain Length: Synthesis and Effect on Histone Deacetylase.Molecules. 2024 Jan 1;29(1):238. doi: 10.3390/molecules29010238. Molecules. 2024. PMID: 38202821 Free PMC article. Review.
-
Comprehensive Study on Thiadiazole-Based Anticancer Agents Inducing Cell Cycle Arrest and Apoptosis/Necrosis Through Suppression of Akt Activity in Lung Adenocarcinoma and Glioma Cells.Turk J Pharm Sci. 2019 Jun;16(2):119-131. doi: 10.4274/tjps.galenos.2019.2018.96658. Epub 2019 Mar 27. Turk J Pharm Sci. 2019. PMID: 32454705 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources